The greener alternative for drug production
Researchers have developed a method using environmentally-friendly water and stable bonding between carbon and manganese instead of highly reactive metals...
List view / Grid view
News
Hormone therapy could be key in treating knee osteoarthritis
A study has found that the prevalence of knee osteoarthritis was significantly lower in participants using hormone therapy than those not taking hormones...
Artificial intelligence used to detect early-stage heart disease
Mayo study uses artificial intelligence to create inexpensive, widely available early detector of heart disease...
Pharmaceutical corridor between Hong Kong and Brussels opens
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
Prescribed opioids raise risk of pneumonia
A study has found that opioids, including morphine, codeine and fentanyl increase the likelihood of patients being affected by pneumonia...
Rising drug prices linked to older products, study finds
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
Ustekinumab could be approved to treat ulcerative colitis
Ustekinumab has been submitted to be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis...
Global APIs market predicted to reach $245.2 billion by 2024
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals...
ADHD drugs unlikely to cause cardiac damage in children
The results of a long-term study on the use of ADHD medication has advised that they are unlikely to result in heart damage, or cardiac difficulties...
FDA clarifies activities during US government shutdown
The FDA has clarified what it can and cannot do in light of the ongoing US government shutdown meaning a lapse in funding during the period...
MHRA announces EU exit no-deal legislative proposals
Innovators should be able to get products to the UK market as quickly and simply as possible, according to the Medicines and Healthcare products Regulatory Agency...
Blood pressure and heart medication recalled by MHRA in UK
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine...
Deloitte finds Pharma returns on R&D reach new low
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010...
Clinical trial to develop breath test for cancer launched
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
Canagliflozin may not be associated with fracture risk in diabetes patients
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
